At the annual conference, we want to highlight not only the technical possibilities of gene and genome sequencing and AI-based evaluation and diagnostic tools, evidence-based prognosis scores, and virtual international exchange platforms, but also discuss international standards for the best possible joint therapy and aftercare. Metastatic disease will also be a focus.
We have already secured a number of highly renowned speakers from Germany and abroad for numerous scientific symposia, including ESMO President Prof. Fabrice André from the Gustave Roussy Institute in Villejuif and Prof. Deborah Schrag from MSKCC in New York, who will present future, simplified clinical trial concepts and inequalities in the treatment of cancer patients.
We have already secured a number of highly renowned speakers from Germany and abroad for numerous scientific symposia, including ESMO President Prof. Fabrice André from the Gustave Roussy Institute in Villejuif and Prof. Deborah Schrag from MSKCC in New York, who will present future, simplified clinical trial concepts and inequalities in the treatment of cancer patients.
Dates